{"id":"W2949447363","doi":"10.1002/art.41012","title":"The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals","keywords":"Tolerability; Osteoarthritis; Placebo; Double blind; Medicine; Joint pain; Clinical trial; Physical therapy; Internal medicine; Adverse effect; Alternative medicine; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002562508,0.001378325,0.002855499,0.0004305076,0.0006521359,0.001092027,0.0008245973,0.002413819,0.00590296],"category_scores_gemma":[0.002162546,0.0007171387,0.000996172,0.000490232,0.001460118,0.0009842968,0.000288552,0.002164541,0.001158097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006054793,"about_ca_system_score_gemma":0.001275891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004950796,"about_ca_topic_score_gemma":0.001054233,"domain_scores_codex":[0.9991515,0.0004998225,0.00007433493,0.0001048429,0.00008139296,0.00008823998],"domain_scores_gemma":[0.999068,0.0002301772,0.0002831231,0.00005848445,0.00007818802,0.0002820383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9698954,0.007285635,0.0003896455,0.0008677224,0.0004741111,0.00003421585,0.00004515769,0.0001917273,0.003647846,0.00009857872,0.0006586098,0.01641133],"study_design_scores_gemma":[0.9579732,0.04034035,0.0005641112,0.00002840288,0.0001552711,0.00002178331,0.0000103286,0.0001930569,0.0003007646,0.00005905977,0.000346658,0.000006975283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700925,0.01119073,0.001476802,0.001349072,0.0007894203,0.01095404,0.001173517,0.0002031122,0.002770773],"genre_scores_gemma":[0.9676791,0.006938713,0.003030998,0.002209148,0.0009334143,0.0146281,0.001040631,0.00003082352,0.003509052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00590296,"threshold_uncertainty_score":0.01974732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02660425493043886,"score_gpt":0.3191045873091085,"score_spread":0.2925003323786696,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}